In­vestors typ­i­cal­ly cel­e­brate IPOs as mile­stone mo­ments — and po­ten­tial ex­it op­por­tu­ni­ties — for their star­tups.
Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of ...
GENEVA, November 12, 2024--Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation GENEVA, November 07, 2024--Alcon Debuts Groundbreaking ...